Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,726 JPY | -0.04% | +0.68% | +15.04% |
Jun. 05 | Kyowa Kirin Repurchases 3.3 Million Shares in May | MT |
May. 07 | Kyowa Kirin's Profit Up 15% in Q1 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.04% | 9.2B | A- | ||
+19.50% | 80.29B | A | ||
-18.33% | 4.67B | A- | ||
+43.39% | 4.49B | - | ||
+13.95% | 4.27B | B- | ||
+10.80% | 2.25B | B | ||
-28.40% | 2.13B | C- | ||
+15.93% | 2.1B | - | - | |
-43.17% | 1.78B | - | ||
-0.50% | 1.64B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 4151 Stock
- Ratings Kyowa Kirin Co. Ltd.